← Leaderboards
Jeffrey R Jacobson
Johns Hopkins University
$5,166,235
Attributed
$6,516,000
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$6,516,000 · 6
By mechanism
R01$4,445,445 · 3
R38$1,339,937 · 1
K08$625,050 · 1
F32$105,568 · 1
Top collaborators
- Steven M Dudek3 shared
- Mark D Mccauley3 shared
- Patricia W Finn1 shared
- David Linn Perkins1 shared
- Jalees Rehman1 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Viswanathan Natarajan$24,234,784
- Richard E Mains$9,772,587
- Melania Maria Bembea$4,528,092
- Carole L Marcus$11,334,904
- Stuart S Martin$11,571,187
Others in their field
Top investigators on “Lung Injury”
- Polly Chang · Sri International$53,674,299
- Asrar B. Malik · University Of Illinois At Chicago$44,050,753
- Edward E Morrisey · University Of Pennsylvania$36,050,545
- Boyd Taylor Thompson · Massachusetts General Hospital$33,582,267
- David Alan Schoenfeld · Massachusetts General Hospital$28,987,839
- Jahar Bhattacharya · St. Luke'S-Roosevelt Inst For Hlth Scis$28,655,382
Research focus
Lung InjuryLungRegulationIn VivoMorbidity - Disease RateEndothelial CellsMediatingGene ExpressionDesignPredispositionTechnologyResponseInterestResearch PersonnelSignal TransductionTherapeutic TargetReceptorAreaGenesPermeabilityNew Therapeutic TargetPhysiciansResearch DesignIntegrins
Grant awards (21)
Fostering Academic Physician-Investigators Treating High Risk Populations$333,296
R38 · FY2024 · HL · contact PI
Sphingolipids as Novel Therapeutic Targets in Radiation Lung Injury$399,750
R01 · FY2023 · HL · contact PI
Fostering Academic Physician-Investigators Treating High Risk Populations$335,547
R38 · FY2023 · HL · contact PI
Sphingolipids as Novel Therapeutic Targets in Radiation Lung Injury$399,750
R01 · FY2022 · HL · contact PI
Fostering Academic Physician-Investigators Treating High Risk Populations$335,547
R38 · FY2022 · HL · contact PI
Precision Medicine in Sarcoidosis$912,947
R01 · FY2021 · HL · contact PI
Sphingolipids as Novel Therapeutic Targets in Radiation Lung Injury$399,750
R01 · FY2021 · HL · contact PI
Fostering Academic Physician-Investigators Treating High Risk Populations$335,547
R38 · FY2021 · HL · contact PI
Sphingolipids as Novel Therapeutic Targets in Radiation Lung Injury$399,750
R01 · FY2020 · HL · contact PI
Integrin Beta 4 in Vascular Inflammatory Responses$369,923
R01 · FY2013 · HL · contact PI
Integrin Beta 4 in Vascular Inflammatory Responses$388,575
R01 · FY2012 · HL · contact PI
Integrin Beta 4 in Vascular Inflammatory Responses$392,500
R01 · FY2011 · HL · contact PI
Integrin Beta 4 in Vascular Inflammatory Responses$392,500
R01 · FY2010 · HL · contact PI
Integrin Beta 4 in Vascular Inflammatory Responses$390,000
R01 · FY2009 · HL · contact PI
Endothelial Barrier Regulation by Simvastatin$125,010
K08 · FY2009 · HL · contact PI
Endothelial Barrier Regulation by Simvastatin$125,010
K08 · FY2008 · HL · contact PI
Endothelial Barrier Regulation by Simvastatin$125,010
K08 · FY2007 · HL · contact PI
Endothelial Barrier Regulation by Simvastatin$125,010
K08 · FY2006 · HL · contact PI
Endothelial Barrier Regulation by Simvastatin$125,010
K08 · FY2005 · HL
Stretch-Induced Changes in Endothelial Contractility$53,484
F32 · FY2003 · HL
Stretch-Induced Changes in Endothelial Contractility$52,084
F32 · FY2002 · HL